REtinal Detachment Outcomes Study

Status Recruiting

Clinical Trial Summary

Background: Few large randomized controlled trials provide strong evidence to guide surgical repair of primary rhegmatogenous retinal detachment (RRD) repair. The purpose of this factorial, single-blind, randomized controlled trial is to analyze and compare the surgical outcomes, functional visual outcomes, complications, and quality of life associated with RRD repair using (A) pars plana vitrectomy only (PPV) or PPV with scleral buckle (PPV-SB) and (B) sulfur hexafluoride gas (SF6) or perfluoropropane gas (C3F8) tamponade. Methods: Eligible patients with moderately complex RRD will be randomized 1:1 to PPV or PPV-SB and 1:1 to SF6 or C3F8 gas tamponade. Approximately 560 patients will be recruited to be able to detect a difference of around 10% in SSAS rate between groups. Patients will be followed using multimodal imaging and quality of life questionnaires before and after the surgical repair until 1 year postoperative. The primary outcome will be single surgery anatomic success (SSAS), defined as absence of reoperation for recurrent RRD in the operating room. Secondary outcomes will be pinhole visual acuity (PHVA) at 8-10 weeks and 6 months, final best-corrected visual acuity (BCVA), final retina status (i.e., attached or detached), time to onset of RRD recurrence, severity and number of complications, and questionnaire results. Discussion: This will be the first 2 × 2 factorial randomized controlled trial examining repair techniques in primary RRD. It will also be the first randomized controlled trial to compare gas tamponade between the two most common agents. Notably, it will be adequately powered to detect a clinically significant effect size. The use of multimodal imaging will also be a novel aspect of this study, allowing us to compare head-to-head the impact of adding an SB to the retina's recovery after RRD repair and of differing gas tamponades. Until now, the treatment of RRD has been largely guided by pragmatic retrospective cohort studies. There is a lack of strong evidence guiding therapeutic decisions and this trial will address (1) whether supplemental SB is justified and (2) whether longer duration gas tamponade with C3F8 is necessary.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05863312
Study type	Interventional
Source	CHU de Quebec-Universite Laval
Contact	Julie Mauger, BSc
Phone	418-682-7511
Email	cuo.recherche@fmed.ulaval.ca
Status	Recruiting
Phase	N/A
Start date	September 26, 2023
Completion date	July 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed	`NCT03660384` - Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy	N/A
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Completed	`NCT04535622` - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery	N/A
Recruiting	`NCT05561569` - Air Versus Gas Tamponade in Primary Retinal Detachment	N/A
Not yet recruiting	`NCT05538156` - Internal Limiting Membrane Peeling in Retinal Detachment Surgery	N/A
Completed	`NCT03046719` - Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal	N/A
Recruiting	`NCT01261533` - Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment	Phase 1
Terminated	`NCT02068625` - Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment	Phase 4
Completed	`NCT00000140` - The Silicone Study	Phase 3
Recruiting	`NCT05543018` - Effect of Intraocular Tamponade on Visual Perception	N/A
Not yet recruiting	`NCT04518696` - Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment	N/A
Completed	`NCT03321253` - Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification	N/A
Completed	`NCT06166914` - Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment	N/A
Enrolling by invitation	`NCT05566626` - Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera	N/A
Not yet recruiting	`NCT03631108` - Feasibility Study and Preliminary Application Study on Iris OCTA
Recruiting	`NCT02201706` - Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye	N/A
Completed	`NCT03218371` - Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.	N/A
Completed	`NCT00000154` - Diabetic Retinopathy Vitrectomy Study (DRVS)	Phase 3
Recruiting	`NCT05583253` - Visual Outcome of Vitrectomy After Refractive Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

REtinal Detachment Outcomes Study — REDOS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms